Exercise-dependent mechanisms of protection in polyglutamine degeneration
多聚谷氨酰胺变性的运动依赖性保护机制
基本信息
- 批准号:10188094
- 负责人:
- 金额:$ 42.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2024-09-30
- 项目状态:已结题
- 来源:
- 关键词:AgingAnimal ModelApplications GrantsAtaxiaAtrophicAutomobile DrivingBiochemistryBiological ModelsBody partCAG repeatCessation of lifeClinicDataDiseaseDisease ProgressionDisease modelDrosophila genusDrosophila inturned proteinDrosophila melanogasterEvaluationExerciseFamilyFamily memberGenesGeneticHealthHumanHuntington DiseaseImpairmentInterventionInvestigationKennedy SyndromeLY6E geneLengthLongevityMJD1 proteinMediatingModelingMolecularMovementNerve DegenerationNervous system structureNeuronal DysfunctionOrganismPathologyPathway interactionsPatientsPhysiologicalProcessProtein BiochemistryProteinsResearchRoleSCA2 proteinSpinocerebellar AtaxiasSymptomsTextbooksTherapeuticTimeTrinucleotide RepeatsType 1 Spinocerebellar AtaxiaVertebratesWheelchairsWorkage relatedbasecell motilitydesignendurance exerciseexercise trainingexperiencefightingflexibilityflyfollow-upimprovedin vivoinsightmembermimeticsnervous system disorderneuroprotectionnew therapeutic targetnovelpolyglutaminepreservationreduce symptoms
项目摘要
The central premise of this exploratory R21 application is to understand endurance exercise-dependent
mechanisms protecting against polyglutamine (polyQ) neurodegeneration. Nine age-related neurological
disorders are caused by abnormal expansion of the CAG triplet repeat of their respective genes. The elongated
CAG repeat encodes an abnormally long polyQ tract that causes neuronal dysfunction and degeneration. These
diseases constitute the polyQ family, which includes Spinocerebellar Ataxias (SCAs) 1, 2, 3, 6, 7 and 17,
Huntington's Disease, Kennedy's Disease and Dentatorubral-pallidolyusian atrophy. Currently, there is no
therapeutic solution for any member of the polyQ family; all patients lose their ability to control movement over
time, invariably becoming wheelchair-bound and experiencing impaired control of other body parts as well.
Endurance exercise is proven to ameliorate disease conditions in various disease models across species. We
recently investigated the potential impact of exercise on loss of mobility in Drosophila melanogaster models of
three polyQ disorders, SCA2, SCA3 and SCA6. We reasoned that using the fruit fly would provide expedient, in
vivo information about conserved molecular pathways and mechanisms that, once characterized and understood,
can be subsequently explored and expanded in vertebrates. Excitingly, we found that daily exercise significantly
and markedly preserved mobility and endurance in aging SCA flies, indicating impaired disease progression.
Based on additional results, we found that improved motility coincided with reduced disease protein levels.
Through this proposal, we seek to expand on these promising observations through two aims that will explore the
protective role of exercise across the spectrum of polyQ diseases, and will define molecular mechanisms that can
be mobilized therapeutically in polyQ disease patients.
这个探索性的R21应用程序的中心前提是了解耐力运动依赖性
防止多聚谷氨酰胺(polyQ)神经变性的机制。9个与年龄相关的神经系统疾病
疾病是由其各自基因的CAG三联体重复的异常扩增引起的。细长
CAG重复序列编码异常长的polyQ束,导致神经元功能障碍和变性。这些
疾病构成polyQ家族,其包括脊髓小脑共济失调(SCA)1、2、3、6、7和17,
亨廷顿氏病、肯尼迪氏病和齿状核红核-苍白球神经萎缩。目前尚无
polyQ家族任何成员的治疗解决方案;所有患者都失去了控制运动的能力,
时间,总是成为轮椅和经验受损的控制其他身体部位以及。
耐力运动被证明可以改善各种疾病模型中的疾病状况。我们
最近研究了运动对黑腹果蝇模型运动能力丧失的潜在影响,
三种polyQ疾病SCA 2 SCA 3和SCA 6。我们推断,使用果蝇将提供权宜之计,
关于保守分子途径和机制的体内信息,一旦表征和理解,
可以随后在脊椎动物中探索和扩展。令人兴奋的是,我们发现每天锻炼
并且在老化的SCA果蝇中显著保留了活动性和耐力,表明疾病进展受损。
基于其他结果,我们发现运动性的改善与疾病蛋白水平的降低相一致。
通过这一提议,我们试图通过两个目标来扩展这些有希望的观测,
运动在polyQ疾病谱中的保护作用,并将定义可以
在polyQ疾病患者中进行治疗动员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sokol Todi其他文献
Sokol Todi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sokol Todi', 18)}}的其他基金
Unique ubiquitin processes in misfolded protein diseases of the nervous system
神经系统错误折叠蛋白疾病中独特的泛素过程
- 批准号:
10284055 - 财政年份:2021
- 资助金额:
$ 42.35万 - 项目类别:
Protection against Alzheimer's Disease proteins by novel ubiquitin processes
通过新型泛素过程预防阿尔茨海默病蛋白
- 批准号:
10283294 - 财政年份:2014
- 资助金额:
$ 42.35万 - 项目类别:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
多谷氨酰胺依赖性变性中神经保护的分子机制
- 批准号:
10115135 - 财政年份:2014
- 资助金额:
$ 42.35万 - 项目类别:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
多谷氨酰胺依赖性变性中神经保护的分子机制
- 批准号:
9811467 - 财政年份:2014
- 资助金额:
$ 42.35万 - 项目类别:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
多谷氨酰胺依赖性变性中神经保护的分子机制
- 批准号:
10369021 - 财政年份:2014
- 资助金额:
$ 42.35万 - 项目类别:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
多谷氨酰胺依赖性变性中神经保护的分子机制
- 批准号:
9018062 - 财政年份:2014
- 资助金额:
$ 42.35万 - 项目类别:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
多谷氨酰胺依赖性变性中神经保护的分子机制
- 批准号:
8667610 - 财政年份:2014
- 资助金额:
$ 42.35万 - 项目类别:
Molecular Mechanisms of Neuroprotection in Polyglutamine-Dependent Degeneration
多谷氨酰胺依赖性变性中神经保护的分子机制
- 批准号:
9234079 - 财政年份:2014
- 资助金额:
$ 42.35万 - 项目类别:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
神经变性中去泛素化酶的翻译后修饰
- 批准号:
8394928 - 财政年份:2009
- 资助金额:
$ 42.35万 - 项目类别:
Posttranslational Modification of Deubiquitinating Enzymes in Neurodegeneration
神经变性中去泛素化酶的翻译后修饰
- 批准号:
7738174 - 财政年份:2009
- 资助金额:
$ 42.35万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




